Discover, Develop & Selectively Deliver Highly Stable & Potent RNAi Therapeutics for Targeted & Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders & Beyond
The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum for translating the next wave of siRNA and microRNA drugs from bench to bedside. As the only event uniting the entire RNAi ecosystem from discovery and complex chemistry to clinical development and CMC, this Summit provides an unparalleled platform to tackle the field's most pressing challenge: delivery beyond the liver. This is your unique opportunity to join 80+ senior leaders from pharma and biotech to gain the data-driven insights and high-value connections needed to overcome stability challenges, de-risk clinical translation, and position your pipeline at the forefront of the next therapeutic revolution.
Attending Companies Include